What is Parkinson's?

Answers to common questions and links to support resources...

About us

Research spotlight

Stopping dopamine neuron degeneration by preventing Alpha-synuclein redistribution

Professor Spillantini and the team at Cambridge university believe that reducing the clumps of alpha-synuclein and restoring normal distribution in nerve endings will reinstate the typical release of dopamine and normal communication between the neurons, thereby reducing the clinical symptoms of Parkinson’s.

How are we closer to the cure this month?

In April 2020, a research group in Shanghai (China), demonstrated that by reducing levels of a single protein in one type of helper cell - the astrocytes - they were able to encourage astrocytes to become neurons. In addition, they found that in mouse models of Parkinson's, those converted astrocytes then went on to become dopamine neurons specifically.

Stopping disease progression

Donate

Fugit quidem aut rerum rem tempore occaecati consequatur. Itaque ut ea aut eligendi ea laborum error. Molestiae repellat ab quas asperiores doloribus. Frequency of donation

Take part in research

PD Frontline Trial

A remote study offering online genetic testing for people with Parkinson’s.

Take a Survery

Fugit quidem aut rerum rem tempore occaecati consequatur.

Our story

Answers to common questions This text will introduce the Cure Parkinsons story and mission…

Our story

Advocate spotlight

Anders Leines, Norway

Fugit quidem aut rerum rem tempore occaecati consequatur. Itaque ut ea aut eligendi ea laborum molestiae repellat ab quas.

Dr Simon Stott

Learn More

Alison Anderson

Learn More

Amarpal Harrar

Learn More

Dr Camille Carroll

Learn More

Maura Ward

Learn More

Nick Light

Learn More

Paul Mayhew-Archer MBE